Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genentech Pipeline Puts Firm Ahead Of 2005 Goals, Sailing To “Horizon 2010”

Oct 17 2005

• By The Pink Sheet

Related Content

Genentech Could Initiate Lucentis Rolling BLA Filing As Early As December

Jul 25 2005

Avastin Pricing Strategy, Expanded Indications Under Review At Genentech

Jul 18 2005

AstraZeneca Iressa Response Working, Company Says: Docs Move To Tarceva

Mar 14 2005

Rituxan Sales Of $37.7 Mil. Offset Declines In Other Genentech Products

Apr 20 1998

Genentech Plans Herceptin Filing In Adjuvant Setting; Survival Benefit Shown

May 23 2005

FDA Takes More Conservative Approach To Quantifying Oncologic Benefit

Sep 26 2005

Genentech Eyes Top Oncology Spot By 2010; No Near-Term Avastin Competitor

Mar 29 2004

Genentech Self-Portrait For 2005

Feb 08 1999

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window